Basilea Pharmaceutica Quote - 0QNA

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Current Price

46.20

Bid

45.05

Offer

47.35

Volume

9,994

0.00 Day's Range 0.00

46.20 52 Week Range 46.20

Market Cap

554.492M

Previous Close

46.20

Open

Last Trade

2000

40.45

(O)

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

3,247

Shares Outstanding

12,002,000

Dividend Yield

PE Ratio

60.67

Earnings Per Share (EPS)

0.87

Revenue

150.28M

Net Profit

10.45M

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.basilea.com

Headquarters

Basel, Che

Founded

Basilea Pharmaceutica Ag is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker 0QNA. The last closing price for Basilea Pharmaceutica was CHF46.20. Over the last year, Basilea Pharmaceutica shares have traded in a share price range of CHF 46.20 to CHF 46.20.

Basilea Pharmaceutica currently has 12,002,000 shares in issue. The market capitalisation of Basilea Pharmaceutica is CHF554.49 million. Basilea Pharmaceutica has a price to earnings ratio (PE ratio) of 60.67.

Strong launch for Cresemba in Japan triggers first sales milestone payment from AKP to Basilea

Strong launch for Cresemba in Japan triggers first sales milestone payment from AKP to Basilea Allschwil, Switzerland, February 05, 2025 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a...

Starker Verkaufsstart von Cresemba in Japan löst erste Umsatzmeilensteinzahlung von AKP an Basilea aus

Starker Verkaufsstart von Cresemba in Japan löst erste Umsatzmeilensteinzahlung von AKP an Basilea aus Allschwil, 05. Februar 2025 Basilea Pharmaceutica AG, Allschwil (SIX: BSLN), ein...

Starkes Verkaufswachstum von Cresemba und Zevtera löst weitere Meilensteinzahlungen an Basilea aus

Starkes Verkaufswachstum von Cresemba und Zevtera löst weitere Meilensteinzahlungen an Basilea aus Allschwil, 28. Januar 2025 Basilea Pharmaceutica AG, Allschwil (SIX: BSLN), ein...

Strong sales growth for Cresemba and Zevtera trigger further milestone payments to Basilea

Strong sales growth for Cresemba and Zevtera trigger further milestone payments to Basilea Allschwil, Switzerland, January 28, 2025 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a...

Basilea informiert über Stand seines Portfolios und gibt Ausblick

Basilea informiert über Stand seines Portfolios und gibt Ausblick Allschwil, 08. Januar 2025 Basilea Pharmaceutica AG, Allschwil (SIX: BSLN), ein biopharmazeutisches Unternehmen mit bereits...

Basilea provides portfolio update and outlook

Basilea provides portfolio update and outlook Allschwil, Switzerland, January 08, 2025 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to...

Basilea is awarded additional CARB-X funding to develop new drug candidate from a novel class of antibiotics

Basilea is awarded additional CARB-X funding to develop new drug candidate from a novel class of antibiotics Additional funding awarded following successful drug candidate nominationUSD 7.3...

Basilea erhält zusätzliche CARB-X-Förderung für die Entwicklung eines Medikamentenkandidaten einer neuen Antibiotika-Wirkstoffklasse

Basilea erhält zusätzliche CARB-X-Förderung für die Entwicklung eines Medikamentenkandidaten einer neuen Antibiotika-Wirkstoffklasse Zusätzliche finanzielle Förderung aufgrund erfolgreicher...

Basilea gibt Vereinbarung mit Innoviva Specialty Therapeutics zur Vermarktung von Antibiotikum Zevtera® (Ceftobiprol) in den Vereinigten Staaten bekannt

Basilea gibt Vereinbarung mit Innoviva Specialty Therapeutics zur Vermarktung von Antibiotikum Zevtera® (Ceftobiprol) in den Vereinigten Staaten bekannt Ad hoc-Mitteilung gemäss Art. 53 KR...

Basilea announces agreement with Innoviva Specialty Therapeutics for the commercialization of antibiotic Zevtera® (ceftobiprole) in the United States

Basilea announces agreement with Innoviva Specialty Therapeutics for the commercialization of antibiotic Zevtera® (ceftobiprole) in the United States Ad hoc announcement pursuant to Art. 53 LR...

Period	Open	High	Low	Avg. Daily Vol	VWAP
1	46.2	46.2	46.2	190	46.2	DE
4	46.2	46.2	46.2	1844	46.2	DE
12	46.2	46.2	46.2	3247	46.2	DE
26	46.2	46.2	46.2	1949	46.2	DE
52	46.2	46.2	46.2	1933	46.2	DE
156	46.2	46.2	46.2	3790	46.2	DE
260	46.2	46.2	46.2	3887	46.2	DE

0QNA - Frequently Asked Questions (FAQ)

What is the current Basilea Pharmaceutica share price?

The current share price of Basilea Pharmaceutica is CHF 46.20

How many Basilea Pharmaceutica shares are in issue?

Basilea Pharmaceutica has 12,002,000 shares in issue

What is the market cap of Basilea Pharmaceutica?

The market capitalisation of Basilea Pharmaceutica is CHF 554.49M

What is the 1 year trading range for Basilea Pharmaceutica share price?

Basilea Pharmaceutica has traded in the range of CHF 46.20 to CHF 46.20 during the past year

What is the PE ratio of Basilea Pharmaceutica?

The price to earnings ratio of Basilea Pharmaceutica is 60.67

What is the cash to sales ratio of Basilea Pharmaceutica?

The cash to sales ratio of Basilea Pharmaceutica is 4.22

What is the reporting currency for Basilea Pharmaceutica?

Basilea Pharmaceutica reports financial results in CHF

What is the latest annual turnover for Basilea Pharmaceutica?

The latest annual turnover of Basilea Pharmaceutica is CHF 150.28M

What is the latest annual profit for Basilea Pharmaceutica?

The latest annual profit of Basilea Pharmaceutica is CHF 10.45M

What is the registered address of Basilea Pharmaceutica?

The registered address for Basilea Pharmaceutica is GRENZACHERSTRASSE 487, BASEL, 4058

What is the Basilea Pharmaceutica website address?

The website address for Basilea Pharmaceutica is www.basilea.com

Which industry sector does Basilea Pharmaceutica operate in?

Basilea Pharmaceutica operates in the PHARMACEUTICAL PREPARATIONS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
GFINGfinity Plc	0.095p (72.73%)	566.77M
XSGXeros Technology Group Plc	0.70p (33.33%)	20.5M
OMIOrosur Mining Inc	9.55p (29.93%)	11.18M
SNGSynairgen Plc	2.49p (27.86%)	229.51k
IKAIlika Plc	34.25p (26.85%)	1.58M
WBIWoodbois Limited	0.0525p (-36.36%)	546.31M
CRVCraven House Capital Plc	US$ 0.275 (-26.67%)	49.99k
KRPZKropz Plc	0.85p (-26.09%)	432.89k
MACMarechale Capital Plc	2.35p (-24.19%)	26.92M
TRCThe Revel Collective Plc	0.175p (-22.22%)	5.52M
NTVONativo Resources Plc	0.0017p (0.00%)	2.07B
GFINGfinity Plc	0.095p (72.73%)	566.77M
WBIWoodbois Limited	0.0525p (-36.36%)	546.31M
OBDOxford Biodynamics Plc	0.55p (10.00%)	369.77M
MSMNMosman Oil And Gas Limited	0.04p (-8.05%)	338.97M